Compare · RKDA vs UVV
RKDA vs UVV
Side-by-side comparison of Arcadia Biosciences Inc. (RKDA) and Universal Corporation (UVV): market cap, price performance, sector, and recent activity on the wire.
Summary
- RKDA operates in Consumer Staples, while UVV operates in Industrials - the two are in different parts of the market.
- UVV is the larger of the two at $1.34B, about 608.8x RKDA ($2.2M).
- Over the past year, RKDA is down 81.6% and UVV is down 12.9% - UVV leads by 68.7 points.
- UVV has hit the wire 21 times in the past 4 weeks while RKDA has been quiet.
- RKDA has more recent analyst coverage (1 ratings vs 0 for UVV).
- Company
- Arcadia Biosciences Inc.
- Universal Corporation
- Price
- $0.92-12.61%
- $53.06-1.30%
- Market cap
- $2.2M
- $1.34B
- 1M return
- -20.90%
- -1.38%
- 1Y return
- -81.61%
- -12.87%
- Industry
- Farming/Seeds/Milling
- Farming/Seeds/Milling
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 0
- 21
- Recent ratings
- 1
- 0
Arcadia Biosciences Inc.
Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.
Universal Corporation
Universal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products. The company contracts, purchases, processes, and sells flue-cured, burley, and oriental tobaccos that are primarily used in the manufacture of cigarettes; and dark air-cured tobaccos principally used in the manufacture of cigars, natural wrapped cigars and cigarillos, smokeless, and pipe tobacco products. It also provides value-added services, including blending, chemical, and physical testing of tobacco; service cutting for various manufacturers; manufacturing reconstituted leaf tobacco; just-in-time inventory management services; electronic nicotine delivery systems; and smoke testing services for customers. In addition, the company offers testing services for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors; and analytical services that include chemical compound testing in finished tobacco products and mainstream smoke. Further, it provides a various value-added manufacturing processes to produce specialty vegetable and fruit-based ingredients for the food and beverage end markets, as well as provides water pipe style leaf tobacco; and recycles waste materials from tobacco production. The company was founded in 1886 and is headquartered in Richmond, Virginia.
Latest RKDA
- SEC Form 10-Q filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
- Amendment: SEC Form 10-K/A filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- SEC Form 10-K filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
- SEC Form EFFECT filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest UVV
- Director Sledd Robert C sold $153,986 worth of shares (2,845 units at $54.12), decreasing direct ownership by 19% to 11,959 units (SEC Form 4)
- VP & Controller Bleicher Scott J was granted 3,770 shares and covered exercise/tax liability with 673 shares, increasing direct ownership by 18% to 20,169 units (SEC Form 4) (tax liability)
- Chief Human Resources Officer Santos Godoi Tatiana was granted 2,515 shares, increasing direct ownership by 127% to 4,492 units (SEC Form 4)
- Senior VP & Sales Director Starke Mckeen was granted 4,081 shares and covered exercise/tax liability with 484 shares, increasing direct ownership by 47% to 11,200 units (SEC Form 4) to satisfy withholding tax
- VP, Ingredients O'Keefe John Patrick was granted 6,993 shares and covered exercise/tax liability with 1,366 shares, increasing direct ownership by 35% to 21,665 units (SEC Form 4) (withholding tax)
- VP, Gen. Counsel & Secretary Claiborne Catherine H was granted 10,393 shares and covered exercise/tax liability with 1,041 shares, increasing direct ownership by 33% to 37,593 units (SEC Form 4) to cover withholding tax
- Senior VP & CFO Diel Steven S. covered exercise/tax liability with 183 shares and was granted 5,778 shares, increasing direct ownership by 19% to 35,172 units (SEC Form 4) (withholding obligation)
- Senior VP & COO Hentschke Airton L covered exercise/tax liability with 4,276 shares and was granted 20,246 shares, increasing direct ownership by 12% to 144,163 units (SEC Form 4) (for tax liability)
- Chairman, President & CEO Wigner Preston Douglas was granted 25,326 shares and covered exercise/tax liability with 2,001 shares, increasing direct ownership by 22% to 127,253 units (SEC Form 4) (withholding tax)
- Senior VP & COO Hentschke Airton L covered exercise/tax liability with 9,485 shares, decreasing direct ownership by 7% to 128,193 units (SEC Form 4) to satisfy withholding obligation